SYNthesis BioVentures
SYNthesis BioVentures is a Privately Held venture capital investor founded in 2022 with headquarters in Australia. The company manages a fund (SYNthesis Bioventures Fund I) focused on investing in early-stage therapeutics, including small molecule therapeutics, biologics and cell and gene therapies for indications with significant unmet need, from discovery through preclinical proof of concept and IND-enabling studies. Industries it has a preference for include: Biotechnology, Healthcare, Medical Devices & Equipment, Pharmaceuticals.